Bertram Pitt

20.8k total citations · 5 hit papers
116 papers, 12.5k citations indexed

About

Bertram Pitt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bertram Pitt has authored 116 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cardiology and Cardiovascular Medicine, 63 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bertram Pitt's work include Hormonal Regulation and Hypertension (59 papers), Heart Failure Treatment and Management (45 papers) and Blood Pressure and Hypertension Studies (30 papers). Bertram Pitt is often cited by papers focused on Hormonal Regulation and Hypertension (59 papers), Heart Failure Treatment and Management (45 papers) and Blood Pressure and Hypertension Studies (30 papers). Bertram Pitt collaborates with scholars based in United States, France and United Kingdom. Bertram Pitt's co-authors include Faı̈ez Zannad, Jay H. Kleiman, Barbara Roniker, Felipe A. Martínez, Richard M. Bittman, Marjorie Gatlin, Dirk J. van Veldhuisen, James D. Neaton, Willem J. Remme and Henry Krum and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Bertram Pitt

109 papers receiving 11.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

2003 3.4k citations Bertram Pitt, Faı̈ez Zannad et al. profile →
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

2010 2.0k citations Faı̈ez Zannad, John J.V. McMurray et al. profile →
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1997 1.2k citations Bertram Pitt et al. profile →
Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease

1999 612 citations Bertram Pitt et al. profile →
The renin-angiotensin-aldosterone system and its suppression

2019 299 citations Marisa K. Ames, Clarke E. Atkins et al. Journal of Veterinary Internal Medicine profile →

Peers

Countries citing papers authored by Bertram Pitt

Since Specialization

Citations

This map shows the geographic impact of Bertram Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertram Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertram Pitt more than expected).

Fields of papers citing papers by Bertram Pitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertram Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertram Pitt. The network helps show where Bertram Pitt may publish in the future.

Co-authorship network of co-authors of Bertram Pitt

This figure shows the co-authorship network connecting the top 25 collaborators of Bertram Pitt. A scholar is included among the top collaborators of Bertram Pitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertram Pitt. Bertram Pitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes By Diuretic Use: A FIDELITY Analysis 2025 ·European Journal of Heart Failure ·Robert J. Mentz, Stefan D. Anker, Bertram Pitt, Peter Rossing, Luís M. Ruilope, Martin Gebel, Peter Kolkhof, Robert Lawatscheck, Katja Rohwedder, George L. Bakris	0
2	Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction 2025 ·JACC Heart Failure ·Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt, Tor Biering‐Sørensen, Akshay S. Desai, Eldrin F. Lewis, Pardeep S. Jhund, Finnian R. Mc Causland, Inder S. Anand, Marc A. Pfeffer, Bertram Pitt, (unknown), Michael R. Zile, John J.V. McMurray, Scott Solomon, Muthiah Vaduganathan	2
3	Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction 2025 ·American Heart Journal ·(unknown), Lina Benson, Gianluigi Savarese, Camilla Hage, Federica Guidetti, Tonje Thorvaldsen, Bertram Pitt, Lars H. Lund	0
4	Finerenone Across the Spectrum of Kidney Risk in Heart Failure 2025 ·JACC Heart Failure ·John W. Ostrominski, Finnian R. Mc Causland, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, (unknown), Michele Senni, (unknown), Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Patrick Schloemer, Meike Brinker, Markus F. Scheerer, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan	3
5	Finerenone, Glycaemic Status, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial 2025 ·European Journal of Heart Failure ·Jawad H. Butt, Pardeep S. Jhund, Alasdair Henderson, Brian Claggett, Akshay S. Desai, (unknown), Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Andrea Lage, Katja Rohwedder, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D Solomon, John J.V. McMurray	0
6	The Future of Clinical Trials 2024 ·Circulation ·Faı̈ez Zannad, Bertram Pitt	0
7	Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial 2024 ·Circulation ·Sanjay Rajagopalan, Mirela Dobre, Jean‐Eudes Dazard, (unknown), Kim A. Connelly, Michael E. Farkouh, Juan Gaztañaga, (unknown), (unknown), (unknown), Anas Fares, (unknown), (unknown), Mark J. Cameron, Cheryl Cameron, Sadeer Al‐Kindi, Robert D. Brook, Bertram Pitt, Matthew R. Weir	5
8	Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease 2024 ·Hypertension ·Bertram Pitt, Javier Dı́ez	3
9	Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure 2024 ·Circulation ·Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, James Lay‐Flurrie, Prabhakar Viswanathan, Markus F. Scheerer, Andrea Lage, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon	25
10	Time to Clinical Benefit of Eplerenone Among Patients with Heart Failure and Reduced Ejection Fraction: A Subgroups Analysis from the EMPHASIS-HF Trial 2023 ·European Journal of Heart Failure ·Luca Monzo, Nicolas Girerd, Kévin Duarte, João Pedro Ferreira, John J.V. McMurray, Dirk J. van Veldhuisen, Karl Swedberg, Stuart Pocock, Bertram Pitt, Faı̈ez Zannad	8
11	A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample population 2021 ·IJC Heart & Vasculature ·(unknown), Jennifer Goldschmied, (unknown), (unknown), (unknown), Bertram Pitt, J. Todd Arnedt, Srijan Sen, Gregory W. Dalack, Patricia J. Deldin	1
12	The renin-angiotensin-aldosterone system and its suppression breakdown → 2019 ·Journal of Veterinary Internal Medicine ·Marisa K. Ames, Clarke E. Atkins, Bertram Pitt	299
13	Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial 2015 ·European Heart Journal ·Nicolas Girerd, Timothy Collier, Stuart Pocock, Henry Krum, John J.V. McMurray, Karl Swedberg, Dirk J. van Veldhuisen, John B. Vincent, Bertram Pitt, Faı̈ez Zannad	23
14	Effect of Eplerenone in Percutaneous Coronary Intervention-Treated Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Subanalysis of the EPHESUS Trial 2014 ·European Journal of Heart Failure ·Javaid Iqbal, Renaud Fay, David Adlam, Iain Squire, Yasir Parviz, Julian Gunn, Bertram Pitt, Faı̈ez Zannad	10
15	Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study 2011 ·European Journal of Heart Failure ·Bertram Pitt, Roberto Latini, Aldo P. Maggioni, Scott D. Solomon, Beverly A. Smith, (unknown), Margaret F. Prescott, John J.V. McMurray	20
16	Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure 2005 ·Journal of the American College of Cardiology ·Bertram Pitt, Harvey D. White, José Carlos Nicolau, Felipe A. Martínez, Mihai Gheorghiade, Michael Aschermann, Dirk J. van Veldhuisen, Faı̈ez Zannad, Henry Krum, Robin Mukherjee, John Vincent	266
17	Generic drugs in cardiology: will they reduce health care costs? 2004 ·Journal of the American College of Cardiology ·Bertram Pitt	13
18	Aldosterone as a target in congestive heart failure 2003 ·Medical Clinics of North America ·Sanjay Rajagopalan, Bertram Pitt	29
19	Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality 1989 ·Journal of the American College of Cardiology ·Eric Bates, Robert M. Califf, Richard S. Stack, Lynne Aronson, Barry S. George, Richard J. Candela, Dean J. Kereiakes, Charles W. Abbottsmith, Linda C. Anderson, Bertram Pitt, William W. O’Neill, Eric J. Topol	75
20	Superoxide dismutase does not cause scar thinning after myocardial infarction 1987 ·Journal of the American College of Cardiology ·S.W. Werns, Michael J. Shea, Ara A. Vaporciyan, Sem H. Phan, Gerald D. Abrams, Andrew J. Buda, Bertram Pitt, Benedict R. Lucchesi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact